Whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography demonstrating multiple rare extracranial metastases in a treated case of glioblastoma

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults that accounts for nearly 20% of all primary malignant brain tumors. While GBM is notable for local recurrence and invasion, extracranial metastases (ECMs) are exceedingly rare, occurring in <2% of patients. However, the repor...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of nuclear medicine Vol. 38; no. 3; pp. 294 - 296
Main Authors Kamaleshwaran, Koramadai, Ramkumar, Elumalai, Raghunathan, Madhu
Format Journal Article
LanguageEnglish
Published Mumbai Wolters Kluwer India Pvt. Ltd 01.07.2023
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Wolters Kluwer - Medknow
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Glioblastoma (GBM) is the most aggressive primary brain tumor in adults that accounts for nearly 20% of all primary malignant brain tumors. While GBM is notable for local recurrence and invasion, extracranial metastases (ECMs) are exceedingly rare, occurring in <2% of patients. However, the report of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) imaging in evaluating ECM is limited, and the importance of whole-body FDG PET/CT imaging in GBM has not been well elucidated. We present here a case of GBM, post excision 12 years before, whole-body 18F-FDG PET/CT showing no recurrence in the brain and ECM to multiple bones, right kidney, and pancreas.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0972-3919
0974-0244
DOI:10.4103/ijnm.ijnm_167_22